BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Azur Pharma Inc. 

1818 Market Street
Suite 2350
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-832-3750 Fax: 215-832-3789


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Jazz Pharmaceuticals, Inc. (JAZZ) and Azur Pharma Inc. Combine to Create Jazz Pharmaceuticals plc 1/18/2012 7:25:24 AM    More...
Jazz Pharmaceuticals, Inc. (JAZZ) to Hold Investor Conference Call on January 5 to Discuss 2012 Financial Guidance and Azur Pharma Inc. Transaction 1/4/2012 10:05:20 AM    More...
Azur Pharma Inc. Release; 2011 Consensus Panel Issues New Guidelines for Intrathecal Pain Management 12/19/2011 10:50:06 AM    More...
Jazz Pharmaceuticals, Inc. (JAZZ) Announces Stockholder Vote in Favor of Transaction With Azur Pharma Inc. 12/13/2011 9:23:41 AM    More...
Jazz Pharmaceuticals, Inc. (JAZZ) Soars as Analyst Praises Move to Buy Azur Pharma Inc.; Companies Combine to Form Jazz Pharmaceuticals plc 9/20/2011 5:58:54 AM    More...
BioSante Pharmaceuticals, Inc. (BPAX) Reports Receipt of $2.16 Million in Elestrin(TM) Royalty Buydown With Azur Pharma Inc., and Financial Results for 2009 3/30/2010 9:06:32 AM    More...
Azur Pharma Inc. to Acquire Elan Corporation PLC (ELN)'s Painkiller Prialt 3/12/2010 7:34:08 AM    More...
Azur Pharma Inc. Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan CNS/Pain Specialty Infrastructure 3/11/2010 8:36:51 AM    More...
Azur Pharma Inc. Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB Two Marketed CNS Products With U.S. Revenues of $20 Million Two FDA Approved but Unlaunched Products 1/9/2009 9:56:19 AM    More...
Antares Pharma, Inc. (ANTR) Receives Milestone Payment and Additional Patent Related to Elestrin(R) 1/6/2009 8:44:32 AM    More...
12

//-->